Viedoc part of large, global Covid-19 vaccine study in China
Viedoc Technologies achieves certification to ISO/IEC 27001:2013
Viedoc participates at SCDM in Shanghai
Viedoc signs deal with WDB Clinical Research
Six reasons to choose Viedoc’s new study-build training
Viedoc Meets — GCP-Service International
Viedoc meets Linical Americas
Walvax Biotechnology chooses Viedoc to run China first COVID-19 mRNA phase III vaccine trial
"Viedoc makes building a study easy and fun. It doesn't require extensive coding knowledge; it's quick to get in and start working."
